Visits: 1801, Avg visit time (secs): 177,25 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 577 | 32,04% | |
| /recipients.html | 451 | 25,04% |
| /amylin/efsd-amylin-recipients.html | 106 | 5,89% |
| /lifescan/efsd-lifescan-recipients.html | 79 | 4,39% |
| /lilly/efsd-lilly-recipients.html | 41 | 2,28% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 37 | 2,05% |
| /cr grant/efsd-clinres-recipients.html | 34 | 1,89% |
| /dcure/efsd-dcure-recipients.html | 30 | 1,67% |
| /lilly/efsd-cds-lilly-fs-recipients.html | 29 | 1,61% |
| /jnj/efsd-jnj-recipients.html | 20 | 1,11% |
| /gsk/efsd-gsk-recipients.html | 18 | 1,00% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 761 | 42,25% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 90 | 5,00% |
| /lilly/efsd-lilly-recipients.html | 84 | 4,66% |
| /dcure/efsd-dcure-recipients.html | 83 | 4,61% |
| /lilly/efsd-lilly-mh-recipients.html | 79 | 4,39% |
| /programmes.html | 60 | 3,33% |
| /amylin/efsd-amylin-recipients.html | 42 | 2,33% |
| /reports.html | 38 | 2,11% |
| /home.html | 33 | 1,83% |
| /gsk/efsd-gsk-recipients.html | 31 | 1,72% |
| /bms/efsd-bms-recipients.html | 27 | 1,50% |